Wayne’s participation, along with countless others, has had a ripple effect that extends far beyond patients.
“What Wayne has done is help contribute to a change in the way prostate cancer is treated. By being brave enough to volunteer his time to a clinical trial, Wayne has not only got access to a valuable treatment, he has also contributed to research which has allowed the medicine to be listed on the Pharmaceutical Benefits Scheme, making it accessible to a wider range of patients,” says Deme.
Seeing patients benefit from trials is incredibly rewarding for medical professionals like Deme, who are dedicated to advancing health care.
Inspired by his experience, Wayne encourages others to consider participating.
“Always ask about trials during your consultations. Whenever I get the opportunity, I tell people to ask about trials,” says Wayne.
NBMLHD clinical trials meet ethical and the scientific quality standards to ensure outcomes can be embedded as best practice and routine care. For patients considering participating in a clinical trial, you are encouraged to speak with your treating team regarding opportunities and whether you qualify as a suitable candidate.
Clinical Trials Day is celebrated globally on 20 May to recognize the day that James Lind, a ship’s surgeon in the British Royal Navy, started what is often considered the first randomised clinical trial (in this case, to study the effects of different treatments on scurvy in sailors), on 20 May 1774.